Panel Discussion: Overcoming Challenges with Access to Tissues & Patient Samples to Build Better Patient-Derived Tumor Models & Enhance Translational Success
3:40 pm - Wednesday 29th July 2026
- Highlighting why high quality, well annotated patient derived samples are essential for building tumor models that truly reflect human disease and improve translational confidence
- Delving into how collaboration between drug developers, clinicians, and model providers accelerates access to the right tissues at the right time and strengthens preclinical decision making
- Discussing practical strategies to overcome ethical, logistical, and operational barriers i tissue procurement to enhance reproducibility and boost trust in model‑derived data
Speakers:
Group Director, Tumor Immunobiology, Clinical Icc Discovery, Oncology Research & Development
AstraZeneca
